| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.689 | 0 | 2.866 | 10.475 | 13.394 | 6.737 | 16.675 | 40.129 | 36.251 | 27.821 |
| Total Income - EUR | 6.698 | 0 | 2.866 | 10.475 | 13.394 | 8.738 | 16.675 | 40.130 | 36.251 | 27.821 |
| Total Expenses - EUR | 9.335 | 1.207 | 1.775 | 5.140 | 6.381 | 14.412 | 13.788 | 11.737 | 35.252 | 40.392 |
| Gross Profit/Loss - EUR | -2.637 | -1.207 | 1.090 | 5.335 | 7.013 | -5.674 | 2.887 | 28.393 | 999 | -12.571 |
| Net Profit/Loss - EUR | -2.838 | -1.207 | 1.004 | 5.021 | 6.609 | -5.876 | 2.387 | 27.396 | 637 | -13.406 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dezidal Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 633 | 486 | 344 | 207 | 645 | 1.863 | 2.279 | 37.578 | 28.803 |
| Current Assets | -2 | 7 | 987 | 1.777 | 8.550 | 1.926 | 6.874 | 30.884 | 14.422 | 15.876 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 561 | 1.809 | 0 | 0 | 4.535 | 57 | 7.371 |
| Cash | -2 | 7 | 987 | 1.215 | 6.741 | 1.926 | 6.874 | 26.349 | 14.365 | 8.505 |
| Shareholders Funds | -2.932 | -4.109 | -3.036 | 2.041 | 8.611 | 2.571 | 4.901 | 32.312 | 32.851 | 19.262 |
| Social Capital | 0 | 56 | 55 | 54 | 53 | 52 | 51 | 51 | 51 | 50 |
| Debts | 2.929 | 4.749 | 4.509 | 80 | 146 | 0 | 3.836 | 851 | 19.149 | 25.418 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Dezidal Med Srl